ConductScience.org, home

Paper35277

Evolution of antihypertensive therapy.

McLeod SM. Can Med Assoc J, 1979. Cited by 1 paper, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Evolution of antihypertensive therapy. Papers, record 35277. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35277

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Evolution of antihypertensive therapy.
PubMed
Journal
Can Med Assoc J
PubMed
Year
1979
PubMed
Publication types
Editorial
PubMed
Citations, by iCite
1
iCite
Relative citation ratio, by iCite
0.08
iCite
Revised in PubMed
2018-11-13
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1McLeod SMS M

Source PubMed

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antihypertensive AgentsMajor topic
HypertensionMajor topic
Adrenergic beta-Antagonists
Angiotensin-Converting Enzyme Inhibitors
Diuretics
Humans

Source PubMed

References6

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114,120,833HYPOTENSIVE ACTION OF PRONETHALOL.Br Med J1964https://conductscience.org/library/papers/14120833PubMed
2205,788Antihypertensive effect of the oral angiotensin converting-enzyme inhibitor SQ 14225 in man.N Engl J Med1978https://conductscience.org/library/papers/205788PubMed
325,707Treatment of arterial hypertension with tienilic acid, a new diuretic with uricosuric properties.Can Med Assoc J1978https://conductscience.org/library/papers/25707PubMed
4334,436Antihypertensive and biochemical effects of chlorthalidone.Clin Pharmacol Ther1977https://conductscience.org/library/papers/334436PubMed
5354,839Dose response to chlorthalidone in patients with mild hypertension. Efficacy of a lower dose.Clin Pharmacol Ther1978https://conductscience.org/library/papers/354839PubMed
6668,773Antihypertensive effect of various doses of hydrochlorothiazide and its relation to the plasma level of the drug.Eur J Clin Pharmacol1978https://conductscience.org/library/papers/668773PubMed

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
7,286,056The pharmacokinetics of trichlormethiazide in hypertensive patients with normal and compromised renal function.Eur J Clin Pharmacol1981https://conductscience.org/library/papers/7286056

Source PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35277

GET https://conductscience.org/api/papers/v1/35277/authors